Nordea Investment Management AB Has $5.23 Million Holdings in Doximity, Inc. $DOCS

Nordea Investment Management AB grew its holdings in Doximity, Inc. (NASDAQ:DOCS) by 28.5% during the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 85,439 shares of the company’s stock after purchasing an additional 18,970 shares during the period. Nordea Investment Management AB’s holdings in Doximity were worth $5,233,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the business. New York State Teachers Retirement System raised its holdings in shares of Doximity by 0.6% in the second quarter. New York State Teachers Retirement System now owns 113,773 shares of the company’s stock valued at $6,979,000 after purchasing an additional 628 shares during the last quarter. Vanguard Personalized Indexing Management LLC raised its holdings in shares of Doximity by 18.4% in the second quarter. Vanguard Personalized Indexing Management LLC now owns 18,733 shares of the company’s stock valued at $1,150,000 after purchasing an additional 2,917 shares during the last quarter. Fourpath Capital Management LLC acquired a new position in Doximity during the second quarter worth $200,000. Blair William & Co. IL increased its holdings in Doximity by 7.8% during the second quarter. Blair William & Co. IL now owns 17,350 shares of the company’s stock worth $1,064,000 after buying an additional 1,259 shares during the last quarter. Finally, Louisiana State Employees Retirement System increased its holdings in Doximity by 0.5% during the second quarter. Louisiana State Employees Retirement System now owns 37,600 shares of the company’s stock worth $2,306,000 after buying an additional 200 shares during the last quarter. 87.19% of the stock is currently owned by institutional investors and hedge funds.

Doximity Price Performance

NASDAQ:DOCS opened at $67.93 on Wednesday. Doximity, Inc. has a one year low of $40.87 and a one year high of $85.21. The company has a market cap of $12.72 billion, a P/E ratio of 67.93, a P/E/G ratio of 4.10 and a beta of 1.38. The firm’s fifty day moving average price is $69.46 and its two-hundred day moving average price is $61.48.

Doximity (NASDAQ:DOCS) last announced its earnings results on Thursday, August 7th. The company reported $0.36 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.31 by $0.05. Doximity had a net margin of 36.60% and a return on equity of 21.75%. During the same period in the previous year, the firm earned $0.28 earnings per share. The business’s revenue for the quarter was up 15.2% on a year-over-year basis. Doximity has set its FY 2026 guidance at EPS. Q2 2026 guidance at EPS. As a group, equities research analysts expect that Doximity, Inc. will post 0.99 earnings per share for the current year.

Insider Activity at Doximity

In related news, Director Regina M. Benjamin sold 5,000 shares of the company’s stock in a transaction dated Friday, October 10th. The shares were sold at an average price of $70.84, for a total value of $354,200.00. Following the transaction, the director directly owned 19,839 shares in the company, valued at approximately $1,405,394.76. This represents a 20.13% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director Kira Scherer Wampler sold 2,000 shares of the company’s stock in a transaction dated Friday, August 1st. The shares were sold at an average price of $57.09, for a total transaction of $114,180.00. Following the completion of the transaction, the director owned 16,618 shares in the company, valued at $948,721.62. This trade represents a 10.74% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 37,000 shares of company stock worth $2,635,880. Corporate insiders own 31.30% of the company’s stock.

Analyst Upgrades and Downgrades

A number of brokerages recently weighed in on DOCS. Evercore ISI boosted their target price on shares of Doximity from $75.00 to $81.00 and gave the stock an “outperform” rating in a report on Wednesday, October 8th. Zacks Research downgraded shares of Doximity from a “strong-buy” rating to a “hold” rating in a report on Wednesday, August 20th. Bank of America boosted their target price on shares of Doximity from $55.00 to $62.00 and gave the stock a “neutral” rating in a report on Wednesday, June 25th. Piper Sandler boosted their target price on shares of Doximity from $65.00 to $69.00 and gave the stock an “overweight” rating in a report on Monday, August 11th. Finally, Canaccord Genuity Group boosted their target price on shares of Doximity from $59.00 to $67.00 and gave the stock a “hold” rating in a report on Thursday, September 18th. One equities research analyst has rated the stock with a Strong Buy rating, ten have assigned a Buy rating, nine have assigned a Hold rating and two have issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Hold” and an average target price of $69.37.

Doximity Company Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.